AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / PHARMACEUTICAL PREPARATIONS
INTERNET PATENTS CORP
Q · usd
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG001SCSN81
24.15▼ 3.11 (-11.40%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
—
Trailing P/E
—
Price / Sales
EV / Revenue
—
EV / EBITDA
—
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
—
Trading Information
Previous Close
27.26
Day's Range
27.26 – 27.26
52-Week Range
25.28 – 28.06
Volume
17
Avg Volume
415
Share Statistics
Shares Outstanding
Employees
—
Exchange
Q
Listed
—
Share count as of September 25, 2026

INTERNET PATENTS CORP (PTNT) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about INTERNET PATENTS CORP (PTNT)
What is INTERNET PATENTS CORP's Market Cap?
INTERNET PATENTS CORP's Market Cap is $43.0M, based on as-reported figures from SEC (XBRL) filings.
What is INTERNET PATENTS CORP's Price / Sales?
INTERNET PATENTS CORP's Price / Sales is 3.3×, based on as-reported figures from SEC (XBRL) filings.
What is INTERNET PATENTS CORP's Revenue (TTM)?
INTERNET PATENTS CORP's Revenue (TTM) is $13.2M, based on as-reported figures from SEC (XBRL) filings.
What is INTERNET PATENTS CORP's Net Income (TTM)?
INTERNET PATENTS CORP's Net Income (TTM) is -$8.4M, based on as-reported figures from SEC (XBRL) filings.
What is INTERNET PATENTS CORP's EBITDA?
INTERNET PATENTS CORP's EBITDA is -$8.6M, based on as-reported figures from SEC (XBRL) filings.
What is INTERNET PATENTS CORP's Diluted EPS (TTM)?
INTERNET PATENTS CORP's Diluted EPS (TTM) is -4.70, based on as-reported figures from SEC (XBRL) filings.
What is INTERNET PATENTS CORP's EBITDA Margin?
INTERNET PATENTS CORP's EBITDA Margin is -65.3%, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · PTNTAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
REVENUES
Total Revenues—
YoY growth————
OPERATING EXPENSES
Research and Development Expense
Selling, General and Administrative Expense
Gain on sale of Vyleesi————
Gain on purchase commitment————
Total operating expenses
% of revenue1569.5%140.3%6415.8%—
Loss from operations
% of revenue-1469.5%-40.3%-6315.8%—
OTHER INCOME (EXPENSE)
Non-Operating Income (Expense)
Foreign Currency Gain/Loss———
Interest expense
Total other income, net
NET LOSS
% of revenue-1449.1%-36.5%-6260.0%—
Earnings Per Share (Basic)
Earnings Per Share (Diluted)